DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment ...
SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations -- Dosing of the first participant in the Phase 1b ...
Amivantamab combined with FOLFOX or FOLFIRI showed a 51% overall response rate in RAS/BRAF wild-type mCRC patients, with a ...
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback